MARKED MITIGATION OF TRANSPLANT VASCULAR SCLEROSIS IN FasLgld (CD95L) MUTANT RECIPIENTS
Transplantation - United States
doi 10.1097/00007890-199905270-00001
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 1999
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)